Spain’s ministry of science has been eliminated as part of a plan by new People’s Party Prime Minister Mariano Rajoy to cut costs and strengthen the government. The ministry was established in 2000. Four years later, it merged with the ministry of education, until 2008 when Cristina Garmedia was elected science minister. She revised Spain’s […]
Isolating the active ingredients from traditional Chinese medicines (TCMs) in order to develop drugs that meet the Western regulatory definition of a drug compound has long proved challenging. Among the problems is the use of traditional techniques for extraction. To improve the development of such drugs, in 2008, China launched the $1.6 billion Innovative New […]
Singapore’s 2010 gross expenditures on R&D (GERD) increased 7.4% to SGD 6.5 billion ($5.0 billion) according to a national survey. Business expenditures on R&D (BERD) rose 6.0% to SGD 3.9 billion, for which 799 companies were responsible. The BERD for “electronics, infocomms and media,” the largest market category, grew 0.2% to SGD $2.31 billion. The […]
This month, the EPA finalized US standards for mercury and air toxics emissions from power plants. The regulations are expected to affect 1,100 coal-fired units and 300 oil-fired units at a total of 600 power plants. Power plants are responsible for approximately 50% of mercury emissions and 77% of acid gas emissions. The standards provide […]
According to Battelle and R&D Magazine, R&D spending worldwide is estimated to increase 5.2% to $1,402.6 billion in 2012 measured in purchase powered parity, compared to growth of 6.5% in 2011. Asian R&D spending is expected to increase the fastest, rising 9% next year to $514.4 billion to account for 37% of total global R&D […]
In order to meet increasing demands for safety and cost effectiveness, more drugs are being developed with diagnostic tests to target specific patient populations. This summer, the FDA issued guidelines for drug and diagnostic combinations, and the FDA approved two such products: Xalkori for lung cancer and Zelboraf for treating melanoma. The Personalized Medicine Coalition […]
Hong Kong 12/21/11; Hong Kong 12/30/11—Analytical instrument maker and distributor Techcomp began trading its shares on the Main Board of the Hong Kong Stock Exchange on December 21 (see IBO 3/31/11) through a transfer of existing shares. This is a dual listing for the company, whose shares also trade on the Singapore Stock Exchange. As […]
Santa Clara, CA 12/21/11—Agilent has acquired PVR, an Italian vacuum pump manufacturer, for an undisclosed amount. PVR’s product portfolio includes rotary vane vacuum pumps for the industrial market and oil-free micro pumps, rotary lobe vacuum pumps, dry rotary claw vacuum pumps, central vacuum systems, and vacuum accessories for the food, paper, chemical and other industries. […]
Washington, DC 12/30/11; New York, NY 12/30/11—Affymetrix disclosed in a regulatory filing that Tang Capital Partners has filed a class action suit in Santa Clara Superior Court against the company in connection with its acquisition of eBioscience (see IBO 11/30/11). Tang Capital Partners is a holder of the company’s 3.50% Senior Convertible Notes Due 2038. […]
San Diego, CA 12/27/11—Illumina has filed suit against Life Technologies alleging patent infringement of US Patent No. 7,060,431 entitled, “Method of Making and Decoding of Arrays Sensors with Microspheres,” by the Ion Personal Genome Machine (PGM) and Ion OneTouch System. Illumina is seeking a permanent injunction and damages. The suit was filed in the US […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
